Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Ministry of health- Department of epidemiology and disease control
Street 1: 71, Avenue Ibn Sina, Agdal
Street 2:
City: Rabat
Post Code:
Country: Morocco
Phone: 00212537671271
Organization Email:
Web Site:
Other Online Presence:

Focal Point Contact Information

Salutation: Dr
First Name: Yassine
Last Name: Aqachmar
Title: NTP manager
Phone: 00212537671261

Alternate Focal Point Contact Information

Salutation: Dr
First Name: Mounia
Last Name: Addahbi
Title: Medication management unit
Phone: 00212537671261

General Information

Board Constituency: Countries
Is your organization legally registered in your country: Yes
If yes, please enter your registration number:
Organization Type - Primary: Governmental Organization
Organization Type - Secondary: None
Organization Description:
1-Some missions and main focus of work:
a-designing and carrying out diseases control programs
b-ensuring epidemiological surveillance of diseases
c-performing epidemiological investigations and studies
2-We are managing the national anti-tuberculosis programme as the service of respiratory diseases in the ministry of health.
3-Our national strategic plan 2018-2021 to fight tuberculosis in Morocco intends to reduce by 40% deaths due to tuberculosis in 2021. We are acting in accordance with WHO vision and pursuing sustainable development goals to eliminate tuberculosis in Morocco by 2030
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Civil Society and Community Engagement
Delivery of health services and care
Engaging political leaders and ensuring inclusive leadership
Funding, including innovative and optimized approach to funding TB Care
Provision of drugs, diagnostics and commodities
Research and Development
Technical Assistance
Working on Community, Rights and Gender (CRG)
Working on Key Populations related to TB

Other Organization Information

Total number of staff in your organization: 51 - 99
Number of full-time staff who are directly involved with TB: 6 - 10
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
How did you hear about the Stop TB Partnership: Stop TB communications
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Resource mobilization
Are you a member of a Stop TB national partnership: Morocco
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
the service of respiratory diseases in the ministry of health is the entity responsible for the design,the monitoring and the evaluation of the national anti-tuberculosis programme.The service also leads and manages the programme's implementation and coordinate the outlined activities.

Geographical Reach

Which country is your headquarters located in: Morocco
Which countries do you do operate in:
(This includes countries you are conducting activities in)


Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
The goal of the current national strategic plan (NSP), which covers the timeframe from July 2017 to December 2021, is to reduce the number of TB deaths by 40% in 2021 compared to 2015 and, to this end, operational objectives were established. Indeed, this NSP aims at increasing more TB case detection and treatment success rate, especially in highly urbanized regions, through the improvement and strengthening of the existing NTP services, the involvement of all care providers and the reinforcement of TB services for high risk groups and vulnerable populations. We are aiming for the detection of 92% of TB cases in 2021(83% in 2015)and targetting more than 90% of therapeutic success in 2021 (86% in 2015).

Drug-Resistant TB:
the NSP develops and implements the programmatic management of drug-resistant TB.We are aiming for the detection of at least 75% of multi-drug-resistant TB cases in 2021 and targetting more than 80% of therapeutic success in 2021.

in order to still reduce the number of TB deaths, the NSP also aims at improving and strengthening TB/HIV joint activities. We are aiming to test, for HIV, 95% of TB patients and to place 100% of HIV-positive TB patients on antiretroviral drugs according to international guidelines by the end of 2021.

Laboratory Strengthening:
The NSP is aiming to increase access to quality-assured AFB microscopy, to improve the diagnosis of TB among AFB smear-negative TB cases and to increase access to rapid laboratory diagnosis of drug-resistant TB among TB patients considered at risk of M/XDR-TB. It also establishes laboratory quality management system

New Diagnostics:
The NSP introduces the new molecular biology techniques for the diagnosis and treatment of TB and M/XDR-TB in combination of digital radiology: Xpert MTB/RIF, Hain...
The NSP also recommends the LED microscopy technique.

New TB Drugs:
The NSP wants to ensure the adoption of new TB drugs and regimens at the country leve, like short regimens for MDR TB, according to international guidelines

Fundamental Research:
The NSP targets the characterization of human TB using modern biomedical, epidemiological
and clinical approaches, especially for MDR and XDR TB. It also aims to understand the natural history of M. tuberculosis infection in extrapulmonary TB.

The NSP also includes a technical assistance plan which specifies the expertise needed to implement certain interventions and activities, needed to increase early TB case-detection and improve the diagnosis of drug-sensitive and -resistant TB, and TB/HIV co-infection.


Declaration of interests:
No conflicts of interest were delacred.

Application date: September 29, 2017
Last updated: October 30, 2017